Global and China DNA Testing/Diagnostics Market Size, Status and Forecast 2021-2027

DNA Testing/Diagnostics is the determination of bloodlinesand the genetic diagnosis of vulnerabilities to inherited diseases.
With the rising incidences of genetic, infectious, and chronic diseases, reduction in prices of genetic sequencing, DNA Testing/Diagnostics growing adoption of precision medicine diagnostic techniques.

Market Analysis and Insights: Global DNA Testing/Diagnostics Market
The global DNA Testing/Diagnostics market size is projected to reach US$ 24190 million by 2027, from US$ 10880 million in 2020, at a CAGR of 11.6% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global DNA Testing/Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global DNA Testing/Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global DNA Testing/Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global DNA Testing/Diagnostics market.

Global DNA Testing/Diagnostics Scope and Market Size
DNA Testing/Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global DNA Testing/Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PCR-Based Diagnostics
ISH Diagnostics
NGS DNA Diagnosis

Segment by Application
Hospital
Medical Research
Pharmacogenomics Diagnostic Testing

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GE Healthcare
454 Life Sciences
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
Thermo Fisher Scientific
Illumina
Cephide
Hologic
Transgenomic
Siemens Healthcare
Roche Diagnostics
Qiagen
Affymetrix
Agilent Technologies